Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 39.74 % |
3 Month Return | + 62.3 % |
1 Year Return | + 161.78 % |
Market Stats | |
Previous Close | ₹941.35 |
Open | ₹926.00 |
Volume | 45.14K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹777.90Cr |
P/E Ratio | 31.01 |
PEG Ratio | 16.94 |
Market Cap | ₹777.90 Cr |
P/B Ratio | 3.4 |
EPS | 28.64 |
Dividend Yield | 0.38 |
Sector | Pharmaceuticals |
ROE | 20.18 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹777.90 Cr | 533.74% | 0.54 | ₹23 Cr | ₹164 Cr | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Titan Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 5.0 Cr → 6.4 Cr (in ₹), with an average increase of 21.9% per quarter
Best in 3 Years
In the last 3 years, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
Revenue is up for the last 2 quarters, 40.4 Cr → 43.74 Cr (in ₹), with an average increase of 7.6% per quarter
Price Rise
In the last 7 days, Titan Biotech stock has moved up by 27.1%
Best in 1 Year
In the last 1 year, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 44.12% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 55.88% of holdings in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 55.88% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 44.12% | 0.00 | |
Others | 0% | 0.00 |
Titan Biotech Ltd in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (31.01x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (31.01x)
October 18, 2024
Titan Biotech Ltd’s net profit jumped 3.9% since last year same period to ₹6.40Cr in the Q1 2024-2025. On a quarterly growth basis, Titan Biotech Ltd has generated 28% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Titan Biotech Ltd has declared dividend of ₹2 - translating a dividend yield of 0.40%.
Read More about DividendsBearish
Neutral
Bullish
Titan Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.
Titan Biotech Ltd (524717) share price today is ₹981.55
Titan Biotech Ltd is not listed on NSE
Titan Biotech Ltd is listed on BSE
PE Ratio of Titan Biotech Ltd is 31.01
PE ratio = Titan Biotech Ltd Market price per share / Titan Biotech Ltd Earnings per share
Today’s traded volume of Titan Biotech Ltd(524717) is 45.14K.
Today’s market capitalisation of Titan Biotech Ltd(524717) is ₹777.9Cr.
Titan Biotech Ltd(524717 | Price |
---|---|
52 Week High | ₹1017.85 |
52 Week Low | ₹344 |
Titan Biotech Ltd(524717) share price is ₹981.55. It is down -3.57% from its 52 Week High price of ₹1017.85
Titan Biotech Ltd(524717) share price is ₹981.55. It is up 185.33% from its 52 Week Low price of ₹344
Titan Biotech Ltd(524717 | Returns |
---|---|
1 Day Returns | 40.2% |
1 Month Returns | 39.74% |
3 Month Returns | 62.3% |
1 Year Returns | 161.78% |